Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center




A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer

Head/Neck

Head/Neck
II/III
Lockney, Natalie
NCT03952585
NRGHN005

A multicenter Phase II trial of Paclitaxel with and without Nivolumab in Taxane nave, and Nivolumab and Cabozantinib in Taxane pretreated subjects with angiosarcoma.

Sarcoma

Sarcoma
II
Davis, Elizabeth
NCT04339738
NRGSARA091902

PVSRIPO with and without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma.

Melanoma

Melanoma
II
Johnson, Douglas
NCT04577807
VICCMEL20109

A Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC# 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/=1 to <31 Years Old with First Relapse

Multiple Cancer Types

Pediatric Leukemia, Pediatrics
II
Zarnegar-Lumley, Sara
NCT04546399
COGAALL1821

A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Nave Metastatic Anal Cancer Patients

Rectal

Rectal
III
Eng, Cathy
NCT04444921
ECOGGIEA2176

A PHASE 1/2 DOSE ESCALATION AND DOSE EXPANSION STUDY OF MECBOTAMAB VEDOTIN (BA3011) ALONE AND IN COMBINATION WITH NIVOLUMAB IN ADULT AND ADOLESCENT PATIENTS 12 YEARS AND OLDER WITH ADVANCED SOLID TUMORS

Multiple Cancer Types

Miscellaneous, Pediatric Solid Tumors, Pediatrics, Sarcoma
I/II
Davis, Elizabeth
NCT03425279
VICCSAR20117

A Phase II Study of Neoadjuvant Nivolumab plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma.

Not Available
II
Ciombor, Kristen
NCT04751370
ECOGGIEA2201

Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)

Kidney (Renal Cell)

Kidney (Renal Cell)
II
Rini, Brian
NCT05361720
VICCURO21103

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: